Retinal Degeneration in a Rodent Model of Smith-Lemli-Opitz Syndrome

Authors:

Abstract
Smith-Lemli-Opitz syndrome (SLOS) (Online Mendelian Inheritance in Man[OMIM] 270400)1 is the first described exampleof a "multiple congenital anomalies syndrome" and the first in a growing listof human hereditary diseases involving inborn errors of cholesterol biosynthesis.2-4 This often lethal, autosomalrecessive disease affects an estimated 1 in 20 000 to 1 in 60 000primarily white live births worldwide, although the incidence may be as highas 1 in 1590 to 1 in 13 500 (see Battaile et al5),arguably making it the fourth most prevalent autosomal recessive human diseaseknown. The key biochemical features associated with SLOS are abnormal (typicallygrossly elevated) levels of 7-dehydrocholesterol (7DHC), a penultimate precursorof cholesterol, and markedly reduced levels of cholesterol in blood and otherbodily tissues.6-9 Thisabnormality in sterol composition is a consequence of defective activity inthe enzyme 3β-hydroxysterol-Δ7-reductase (EC 1.3.1.21),which catalyzes the conversion of 7DHC to cholesterol.10-12 Theenzymatic defect, in turn, can be ascribed to any one of a myriad of mutationsfound to be associated with the DHCR7 gene (localizedto 11q12-q13), which encodes the Δ7-reductase enzyme.13-15 Patients with SLOSexhibit a constellation of profound phenotypic and functional abnormalities,including microcephaly, holoprosencephaly, dysmorphic craniofacial features,micrognathia, limb asymmetries, syndactyly of the second and third toes, polydactyly,ambiguous genitalia, hypospadias, cleft palate, short nose with antevertednostrils, abnormal visceral development (especially the kidneys, liver, andlungs), hypotonia, failure to thrive, and mental retardation.1-4

This publication has 73 references indexed in Scilit: